|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 2201 to 2300 out of 4306 for C3

0.028s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
First Author: Park K
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: ER stress stimulates production of the key antimicrobial peptide, cathelicidin, by forming a previously unidentified intracellular S1P signaling complex.
Volume: 113
Issue: 10
Pages: E1334-42
Publication
First Author: Riento K
Year: 2018
Journal: PLoS One
Title: Flotillin proteins recruit sphingosine to membranes and maintain cellular sphingosine-1-phosphate levels.
Volume: 13
Issue: 5
Pages: e0197401
Publication
First Author: Hagen N
Year: 2011
Journal: Cell Death Differ
Title: Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanism.
Volume: 18
Issue: 8
Pages: 1356-65
Publication
First Author: Yuan F
Year: 2022
Journal: Cell Death Dis
Title: SphK-produced S1P in somatic cells is indispensable for LH-EGFR signaling-induced mouse oocyte maturation.
Volume: 13
Issue: 11
Pages: 963
Publication
First Author: Isotani A
Year: 2005
Journal: Proc Natl Acad Sci U S A
Title: Genomic imprinting of XX spermatogonia and XX oocytes recovered from XX<-->XY chimeric testes.
Volume: 102
Issue: 11
Pages: 4039-44
Publication
First Author: Zou X
Year: 2003
Journal: J Immunol
Title: Block in development at the pre-B-II to immature B cell stage in mice without Ig kappa and Ig lambda light chain.
Volume: 170
Issue: 3
Pages: 1354-61
Publication
First Author: Niwa H
Year: 1991
Journal: Gene
Title: Efficient selection for high-expression transfectants with a novel eukaryotic vector.
Volume: 108
Issue: 2
Pages: 193-9
Publication
First Author: Verhamme C
Year: 2011
Journal: J Neuropathol Exp Neurol
Title: Myelin and axon pathology in a long-term study of PMP22-overexpressing mice.
Volume: 70
Issue: 5
Pages: 386-98
Publication
First Author: Bai Y
Year: 2022
Journal: Mol Neurobiol
Title: Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B Mice.
Volume: 59
Issue: 7
Pages: 4159-4178
Genotype
Symbol: Tsix/? Tg(CAG-EGFP)50Osb/? Gt(ROSA)26Sor/Gt(ROSA)26Sor
Background: involves: 129P2/OlaHsd * 129S4/SvJae * C3H/HeSlc * C57BL/6J * C57BL/6Slc
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Tsix/Tsix Tg(CAG-EGFP)50Osb/? Gt(ROSA)26Sor/Gt(ROSA)26Sor
Background: involves: 129P2/OlaHsd * 129S4/SvJae * C3H/HeSlc * C57BL/6J * C57BL/6Slc
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Tsix/Tsix<+> Tg(CAG-EGFP)50Osb/? Gt(ROSA)26Sor/Gt(ROSA)26Sor
Background: involves: 129P2/OlaHsd * 129S4/SvJae * C3H/HeSlc * C57BL/6J * C57BL/6Slc
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: C3/C3 Dysf/Dysf
Background: B6.129-Dysf C3
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: C3/C3 Cd59a/Cd59a
Background: B6.129-Cd59a C3
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Tcra/Tcra Tg(Mx1-cre)1Cgn/?
Background: involves: C57BL/6 * CBA
Zygosity: cn
Has Mutant Allele: true
Publication
First Author: Rooryck C
Year: 2011
Journal: Nat Genet
Title: Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome.
Volume: 43
Issue: 3
Pages: 197-203
Publication
First Author: Birtley JR
Year: 2005
Journal: J Biol Chem
Title: Crystal structure of foot-and-mouth disease virus 3C protease. New insights into catalytic mechanism and cleavage specificity.
Volume: 280
Issue: 12
Pages: 11520-7
Publication
First Author: Lee CC
Year: 2009
Journal: J Biol Chem
Title: Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds.
Volume: 284
Issue: 12
Pages: 7646-55
Publication
First Author: Costenaro L
Year: 2011
Journal: J Virol
Title: Structural basis for antiviral inhibition of the main protease, 3C, from human enterovirus 93.
Volume: 85
Issue: 20
Pages: 10764-73
Publication
First Author: Lu G
Year: 2011
Journal: J Virol
Title: Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design.
Volume: 85
Issue: 19
Pages: 10319-31
Publication
First Author: Le Gall O
Year: 2008
Journal: Arch Virol
Title: Picornavirales, a proposed order of positive-sense single-stranded RNA viruses with a pseudo-T = 3 virion architecture.
Volume: 153
Issue: 4
Pages: 715-27
Publication
First Author: Ye S
Year: 2012
Journal: Virology
Title: Identification and characterization of Iflavirus 3C-like protease processing activities.
Volume: 428
Issue: 2
Pages: 136-45
Publication
First Author: Birktoft JJ
Year: 1989
Journal: Biochemistry
Title: Refined crystal structure of cytoplasmic malate dehydrogenase at 2.5-A resolution.
Volume: 28
Issue: 14
Pages: 6065-81
Publication
First Author: Knappe S
Year: 2003
Journal: Plant Physiol
Title: Analysis of the plastidic phosphate translocator gene family in Arabidopsis and identification of new phosphate translocator-homologous transporters, classified by their putative substrate-binding site.
Volume: 131
Issue: 3
Pages: 1178-90
Publication
First Author: Martinez-Duncker I
Year: 2003
Journal: Biochimie
Title: The nucleotide-sugar transporter family: a phylogenetic approach.
Volume: 85
Issue: 3-4
Pages: 245-60
Publication
First Author: Windhövel A
Year: 2001
Journal: Plant Mol Biol
Title: Characterization of a novel class of plant homeodomain proteins that bind to the C4 phosphoenolpyruvate carboxylase gene of Flaveria trinervia.
Volume: 45
Issue: 2
Pages: 201-14
Publication
First Author: Suarez DL
Year: 1997
Journal: J Virol
Title: Size variation within the second hypervariable region of the surface envelope gene of the bovine lentivirus BIV in experimentally and naturally infected cattle.
Volume: 71
Issue: 3
Pages: 2482-6
Publication
First Author: Meas S
Year: 2001
Journal: Arch Virol
Title: Phylogenetic relationships of bovine immunodeficiency virus in cattle and buffaloes based on surface envelope gene sequences. Brief report.
Volume: 146
Issue: 5
Pages: 1037-45
Publication
First Author: Wei M
Year: 2001
Journal: Biochemistry
Title: Investigation of the role of the domain linkers in separate site catalysis by Clostridium symbiosum pyruvate phosphate dikinase.
Volume: 40
Issue: 45
Pages: 13466-73
Publication
First Author: Nakanishi T
Year: 2004
Journal: Acta Crystallogr D Biol Crystallogr
Title: Purification, crystallization and preliminary X-ray diffraction studies on pyruvate phosphate dikinase from maize.
Volume: 60
Issue: Pt 1
Pages: 193-4
Publication
First Author: Chastain CJ
Year: 2002
Journal: Plant Physiol
Title: Pyruvate,orthophosphate dikinase in leaves and chloroplasts of C(3) plants undergoes light-/dark-induced reversible phosphorylation.
Volume: 128
Issue: 4
Pages: 1368-78
Publication
First Author: Arcus VL
Year: 2002
Journal: J Biol Chem
Title: The Three-dimensional structure of a superantigen-like protein, SET3, from a pathogenicity island of the Staphylococcus aureus genome.
Volume: 277
Issue: 35
Pages: 32274-81
Publication
First Author: Al-Shangiti AM
Year: 2004
Journal: Infect Immun
Title: Structural relationships and cellular tropism of staphylococcal superantigen-like proteins.
Volume: 72
Issue: 7
Pages: 4261-70
Publication
First Author: Takayama Y
Year: 1999
Journal: Mol Immunol
Title: Gene structure of the P100 serine-protease component of the human Ra-reactive factor.
Volume: 36
Issue: 8
Pages: 505-14
Publication
First Author: Sulzenbacher G
Year: 2004
Journal: J Mol Biol
Title: Crystal structure of E.coli alcohol dehydrogenase YqhD: evidence of a covalently modified NADP coenzyme.
Volume: 342
Issue: 2
Pages: 489-502
Publication
First Author: Jarboe LR
Year: 2011
Journal: Appl Microbiol Biotechnol
Title: YqhD: a broad-substrate range aldehyde reductase with various applications in production of biorenewable fuels and chemicals.
Volume: 89
Issue: 2
Pages: 249-57
Publication
First Author: Liu X
Year: 2009
Journal: Microbiology (Reading)
Title: Two novel metal-independent long-chain alkyl alcohol dehydrogenases from Geobacillus thermodenitrificans NG80-2.
Volume: 155
Issue: Pt 6
Pages: 2078-2085
Protein Domain
Type: Family
Description: Functionally characterised members of the 6-8 TMS Triose-phosphate Transporter (TPT) family are derived from the inner envelopemembranes of chloroplasts and non-green plastids of plants. Under normal physiological conditions, chloroplast TPTs mediate a strict antiport of substrates, frequently exchanging an organic three carbon compound phosphate ester for inorganic phosphate (Pi) [, ].Normally, a triose-phosphate, 3-phosphoglycerate, or another phosphorylated C3compound made in the chloroplast during photosynthesis, exits the organelle into thecytoplasm of the plant cell in exchange for Pi. However, experiments with reconstituted translocator in artificial membranes indicate that transport can also occur by a channel-like uniport mechanism with up to 10-fold higher transport rates. Channel opening may be induced by a membrane potential of large magnitude and/or by high substrate concentrations. Non-green plastid and chloroplast carriers, such as those from maize endosperm and root membranes, mediate transport of C3 compounds phosphorylated at carbon atom 2, particularly phosphoenolpyruvate, in exchange for Pi. These are the phosphoenolpyruvate:Pi antiporters (PPT). Glucose-6-P has also been shown to be a substrate of some plastid translocators (GPT). The three types of proteins (TPT, PPT and GPT) are divergent in sequence as well as substrate specificity, but their substrate specificities overlap.TPT paralogues are also present in Saccharomyces cerevisiae, which are functionally uncharacterised.
Protein Domain
Type: Homologous_superfamily
Description: The CLIP domain is a regulatory domain which controls the proteinase action of various proteins of the trypsin family, e.g. easter and pap2. The domain is restricted to the arthropoda and found in varying copy numbers (from one to five in Drosophila proteins). It is always found N-terminal to the chymotrypsin serine protease domain, which belong to MEROPS peptidase family S1A. The CLIP domain remains linked to the protease domain after cleavage of a conserved residue which retains the protein in zymogen form. It is named CLIP because it can be drawn in the shape of a paper clip. It has many disulphide bonds and highly conserved cysteine residues, and so it folds extensively [, ]. The clip domain adopts an α/β mixed fold consisting of two helices and an antiparallel distorted β-sheet made of four strands. The two helices are antiparallel and are almost perpendicular to the β-sheet. Three disulfide bridges (C1-C5, C2-C4, C3-C6) stabilize the β-sheet, C3 being the only cysteine that is not located on a β-strand. The clip domain is located opposite the activation loop and contacts the C-terminal α-helix of the SP domain []. The CLIP domain is present in silkworm prophenoloxidase-activating enzyme [].
Protein Domain
Type: Family
Description: These proteins belong to MEROPS peptidase family S1 (chymotrypsin family, clan PA(S)), subfamily S1A.This family contains the mammalian mannan-binding lectin-associated serine proteases 1 and 2 (MASP1 and MASP2) and complement components C1s and C1r. The C1 complex, containing C1q, C1s, and C1r, triggers the classical complement pathway. When C1q interacts with antibody, C1r becomes autocatalytically activated. Activated C1r in turn activates C1s, which then cleaves C2 and C4 in the classical pathway.Mannose-binding lectin (MBL) complexes with MASP1, MASP2, and a smaller alternative splice product of the MASP2 gene. Binding of MBL to carbohydrates on the surface of microorganisms triggers activation of the associated MASPs. Then MASP1 activates C3 and C2, whereas MASP2 activates C4 and C2 []. Based on the fact that the gene structures of MASP1, C1r, and C1s are similar except that C1r and C1s lack introns in the region encoding the trypsin domain, it has been proposed that the MASP proteins evolved earlier than C1r and C1s []. The complement pathway is also involved in development [].These sequences typically contain a signal sequence, followed by a CUB domain, an EGF-like domain (which often is not detected), a second CUB domain, two sushi domains (sometimes only one is detected), and a trypsin domain.
Protein Domain
Type: Family
Description: Pyruvate phosphate dikinase (PPDK, or pyruvate orthophosphate dikinase) is found in plants, bacteria and archaea. The amino acid sequence identity between bacterial and plant enzymes is high, and they are similar in sequence to other PEP-utilizing enzymes. PPDK catalyses the reversible conversion of ATP and pyruvate to AMP and PEP (phosphoenolpyruvate). In bacteria such as Clostridium symbiosum (Bacteroides symbiosus), PPDK uses Mg2+ and NH4+ ions as cofactors []. The enzyme has three domains: the N- and C-terminal domains each have an active site centre that catalyses a different step in the reaction, and the middle domain has a carrier histidine residue that moves between the two active centres.In plants, PPDK is localised predominantly in chloroplast stroma where it catalyses the rate-limiting step in the C4 photosynthetic pathway, namely the synthesis of PEP, which acts as the primary CO2 acceptor in C4 photosynthesis []. PPDK activity in C4 plants is strictly regulated by light, its activity decreasing in darkness. This response is regulated by phosphorylation and dephosphorylation of the enzyme using ADP; such regulation is not seen in the bacterial form of the enzyme. PPDK is also found in C3 plants, but it is not known to have a photosynthetic role [].
Protein Domain
Type: Domain
Description: The CLIP domain is a regulatory domain which controls the proteinase action of various proteins of the trypsin family, e.g. easter and pap2. The domain is restricted to the arthropoda and found in varying copy numbers (from one to five in Drosophila proteins). It is always found N-terminal to the chymotrypsin serine protease domain, which belong to MEROPS peptidase family S1A. The CLIP domain remains linked to the protease domain after cleavage of a conserved residue which retains the protein in zymogen form. It is named CLIP because it can be drawn in the shape of a paper clip. It has many disulphide bonds and highly conserved cysteine residues, and so it folds extensively [, ]. The clip domain adopts an α/β mixed fold consisting of two helices and an antiparallel distorted β-sheet made of four strands. The two helices are antiparallel and are almost perpendicular to the β-sheet. Three disulfide bridges (C1-C5, C2-C4, C3-C6) stabilize the β-sheet, C3 being the only cysteine that is not located on a β-strand. The clip domain is located opposite the activation loop and contacts the C-terminal α-helix of the SP domain []. The CLIP domain is present in silkworm prophenoloxidase-activating enzyme [].
Protein Domain
Type: Conserved_site
Description: This entry contains serum complement C3 and C4 precursors and alpha-macrogrobulins. The alpha-macroglobulin (aM) family of proteins includes protease inhibitors [], typified by the human tetrameric a2-macroglobulin (a2M); they belong to the MEROPS proteinase inhibitor family I39, clan IL. These protease inhibitors share several defining properties, which include (i) the ability to inhibit proteases from all catalytic classes, (ii) the presence of a 'bait region' and a thiol ester, (iii) a similar protease inhibitorymechanism and (iv) the inactivation of the inhibitory capacity by reaction of the thiol ester with small primary amines. aM protease inhibitors inhibit by steric hindrance []. The mechanism involves protease cleavage of the bait region, a segment of the aM thatis particularly susceptible to proteolytic cleavage, which initiates a conformational change such that the aM collapses about the protease. In the resulting aM-protease complex, the active site of the protease is sterically shielded, thus substantially decreasing access to protein substrates. Two additional events occur as a consequence of bait region cleavage, namely (i) the h-cysteinyl-g-glutamyl thiol ester becomes highly reactive and (ii) a major conformational change exposes a conserved COOH-terminal receptor binding domain [](RBD). RBD exposure allows the aM protease complex to bind to clearance receptors and be removed from circulation []. Tetrameric, dimeric, and, more recently, monomeric aM protease inhibitors have been identified [, ].This entry represents a conserved region, located towards the C terminus, which contains the two residues involved in the thiol ester bond.
Protein Domain
Type: Family
Description: Butanol dehydrogenase (BDH) is involved in the final step of the butanol formation pathway, in which it catalyses the conversion of butyraldehyde to butanol with the cofactor NAD(P)H being oxidised in the process. The NADH-BDH has higher activity with longer chained aldehydes and is inhibited by metabolites containing an adenine moiety. This protein family belongs to the so-called iron-containing alcohol dehydrogenase superfamily. Members in this family use divalent ions, preferentially iron or zinc []. This family also includes E. coli YqhD enzyme, an NADP-dependent dehydrogenase whose activity measurements with several alcohols demonstrate preference for alcohols longer than C3 [, ]. The active site of YqhD contains a zinc atom, and a modified NADPH cofactor bearing OH groups on the saturated C5 and C6 atoms, possibly due to oxygen stress on the enzyme, which would functionally work under anaerobic conditions.This entry also includes Long-chain-alcohol dehydrogenase 2 from Geobacillus thermodenitrificans which is able to oxidise a broad range of alkyl alcohols from methanol to 1-triacontanol (C1 to C30), whose best substrate is 1-octanol. In contrast to other members of the family, it apparently does not use iron or other metals as cofactor [].
Protein Domain
Type: Domain
Description: This entry contains serum complement C3 and C4 precursors and alpha-macrogrobulins. The alpha-macroglobulin (aM) family of proteins includes protease inhibitors [, ], typified by the human tetrameric a2-macroglobulin (a2M); they belong to the MEROPS proteinase inhibitor family I39, clan IL. These protease inhibitors share several defining properties, which include (i) the ability to inhibit proteases from all catalytic classes, (ii) the presence of a 'bait region' and a thioester, (iii) a similar protease inhibitory mechanism and (iv) the inactivation of the inhibitory capacity by reaction of the thiol ester with small primary amines. aM protease inhibitors inhibit by steric hindrance []. The mechanism involves protease cleavage of the bait region, a segment of the aM that is particularly susceptible to proteolytic cleavage, which initiates a conformational change such that the aM collapses about the protease. In the resulting aM-protease complex, the active site of the protease is sterically shielded, thus substantially decreasing access to protein substrates. Two additional events occur as a consequence of bait region cleavage, namely (i) the h-cysteinyl-g-glutamyl thiol ester becomes highly reactive and (ii) a major conformational change exposes a conserved COOH-terminal receptor binding domain [](RBD). RBD exposure allows the aM protease complex to bind to clearance receptors and be removed from circulation []. Tetrameric, dimeric, and, more recently, monomeric aM protease inhibitors have been identified [, ].
Protein Domain
Type: Family
Description: (Bovine immunodeficiency virus) (BIV), like the human immunodeficiency virus, is a lentivirus. It shows a great deal of genomic diversity, mostly in the viral envelope gene []. This property of the BIV group of viruses may play an important role in the pathobiology of the virus, particularly the conserved (C) 2, hypervariable (V) 1, V2 and C3 regions [].The surface protein (SU) attaches the virus to the host cell by binding to its receptor. This interaction triggers the refolding of the transmembrane protein (TM) and is thought to activate its fusogenic potential by unmasking its fusion peptide. Fusion occurs at the host cell plasma membrane.The transmembrane protein (TM) acts as a class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes. Membranes fusion leads to delivery of the nucleocapsid into the cytoplasm.
Publication
First Author: Watanabe N
Year: 1997
Journal: EMBO J
Title: p140mDia, a mammalian homolog of Drosophila diaphanous, is a target protein for Rho small GTPase and is a ligand for profilin.
Volume: 16
Issue: 11
Pages: 3044-56
Publication
First Author: Alberts AS
Year: 1998
Journal: EMBO J
Title: Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-specific exchange factor mNET1.
Volume: 17
Issue: 14
Pages: 4075-85
Publication
First Author: Nonaka M
Year: 1985
Journal: J Biol Chem
Title: Complete nucleotide and derived amino acid sequences of the fourth component of mouse complement (C4). Evolutionary aspects.
Volume: 260
Issue: 20
Pages: 10936-43
Publication
First Author: Cachero TG
Year: 1998
Journal: Cell
Title: The small GTP-binding protein RhoA regulates a delayed rectifier potassium channel.
Volume: 93
Issue: 6
Pages: 1077-85
Publication
First Author: Kawamura T
Year: 2001
Journal: Biochem Genet
Title: cDNA of a novel mRNA expressed predominantly in mouse kidney.
Volume: 39
Issue: 1-2
Pages: 33-42
Publication
First Author: Kinoshita M
Year: 1997
Journal: Genes Dev
Title: Nedd5, a mammalian septin, is a novel cytoskeletal component interacting with actin-based structures.
Volume: 11
Issue: 12
Pages: 1535-47
Publication
First Author: Díaz de Ståhl T
Year: 2003
Journal: J Exp Med
Title: A role for complement in feedback enhancement of antibody responses by IgG3.
Volume: 197
Issue: 9
Pages: 1183-90
Publication  
First Author: Ng ESY
Year: 2022
Journal: Cells
Title: Membrane Attack Complex Mediates Retinal Pigment Epithelium Cell Death in Stargardt Macular Degeneration.
Volume: 11
Issue: 21
Publication
First Author: Pore D
Year: 2018
Journal: J Immunol
Title: Cutting Edge: Deletion of Ezrin in B Cells of Lyn-Deficient Mice Downregulates Lupus Pathology.
Volume: 201
Issue: 5
Pages: 1353-1358
Publication
First Author: Bottermann M
Year: 2019
Journal: Cell Host Microbe
Title: Complement C4 Prevents Viral Infection through Capsid Inactivation.
Volume: 25
Issue: 4
Pages: 617-629.e7
Publication
First Author: Welch TR
Year: 2001
Journal: Clin Immunol
Title: Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.
Volume: 101
Issue: 3
Pages: 366-70
Publication    
First Author: Wu B
Year: 2019
Journal: Elife
Title: TRPC3 is a major contributor to functional heterogeneity of cerebellar Purkinje cells.
Volume: 8
Publication
First Author: Litvinchuk A
Year: 2018
Journal: Neuron
Title: Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer's Disease.
Volume: 100
Issue: 6
Pages: 1337-1353.e5
Publication
First Author: Hutchinson WL
Year: 2004
Journal: Immunology
Title: Classical and alternative pathway complement activation are not required for reactive systemic AA amyloid deposition in mice.
Volume: 112
Issue: 2
Pages: 250-4
Publication
First Author: Ling GS
Year: 2018
Journal: Science
Title: C1q restrains autoimmunity and viral infection by regulating CD8+ T cell metabolism.
Volume: 360
Issue: 6388
Pages: 558-563
Publication
First Author: Manderson AP
Year: 2006
Journal: J Immunol
Title: A novel mechanism for complement activation at the surface of B cells following antigen binding.
Volume: 177
Issue: 8
Pages: 5155-62
Publication    
First Author: Griffin P
Year: 2020
Journal: Elife
Title: REV-ERBα mediates complement expression and diurnal regulation of microglial synaptic phagocytosis.
Volume: 9
Publication
First Author: Chang SH
Year: 2019
Journal: Nat Commun
Title: Excessive mechanical loading promotes osteoarthritis through the gremlin-1-NF-κB pathway.
Volume: 10
Issue: 1
Pages: 1442
Publication
First Author: Schonthaler HB
Year: 2013
Journal: Immunity
Title: S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3.
Volume: 39
Issue: 6
Pages: 1171-81
Publication
First Author: Samanta DN
Year: 2005
Journal: J Immunol
Title: B cell hyperresponsiveness and expansion of mature follicular B cells but not of marginal zone B cells in NFATc2/c3 double-deficient mice.
Volume: 174
Issue: 8
Pages: 4797-802
Publication
First Author: Wei J
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: The GTPase-activating protein GIT2 protects against colitis by negatively regulating Toll-like receptor signaling.
Volume: 111
Issue: 24
Pages: 8883-8
Publication
First Author: Bellac CL
Year: 2014
Journal: Cell Rep
Title: Macrophage matrix metalloproteinase-12 dampens inflammation and neutrophil influx in arthritis.
Volume: 9
Issue: 2
Pages: 618-32
Publication
First Author: Hiyama TY
Year: 2010
Journal: Neuron
Title: Autoimmunity to the sodium-level sensor in the brain causes essential hypernatremia.
Volume: 66
Issue: 4
Pages: 508-22
Publication
First Author: Hsu AP
Year: 2019
Journal: Blood
Title: Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects.
Volume: 133
Issue: 18
Pages: 1977-1988
Publication
First Author: Becker EB
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice.
Volume: 106
Issue: 16
Pages: 6706-11
Publication
First Author: Li LZ
Year: 2019
Journal: Neurosci Bull
Title: Rac1 Modulates Excitatory Synaptic Transmission in Mouse Retinal Ganglion Cells.
Volume: 35
Issue: 4
Pages: 673-687
Publication
First Author: Mulfaul K
Year: 2020
Journal: Cell Rep
Title: Toll-like Receptor 2 Facilitates Oxidative Damage-Induced Retinal Degeneration.
Volume: 30
Issue: 7
Pages: 2209-2224.e5
Publication
First Author: Kyriakides C
Year: 1999
Journal: J Appl Physiol (1985)
Title: Membrane attack complex of complement and neutrophils mediate the injury of acid aspiration.
Volume: 87
Issue: 6
Pages: 2357-61
Publication
First Author: Pekna M
Year: 1998
Journal: Scand J Immunol
Title: Mice deficient for the complement factor B develop and reproduce normally.
Volume: 47
Issue: 4
Pages: 375-80
Publication
First Author: Kramerova I
Year: 2004
Journal: Hum Mol Genet
Title: Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro.
Volume: 13
Issue: 13
Pages: 1373-88
Publication
First Author: Davidson S
Year: 2020
Journal: Cell Rep
Title: Single-Cell RNA Sequencing Reveals a Dynamic Stromal Niche That Supports Tumor Growth.
Volume: 31
Issue: 7
Pages: 107628
Publication
First Author: Medgyesi D
Year: 2014
Journal: J Exp Med
Title: The protein tyrosine phosphatase PTP1B is a negative regulator of CD40 and BAFF-R signaling and controls B cell autoimmunity.
Volume: 211
Issue: 3
Pages: 427-40
Publication
First Author: Boughter JD Jr
Year: 1995
Journal: Behav Genet
Title: C3.SW-Soaa heterozygous congenic taster mice.
Volume: 25
Issue: 3
Pages: 233-7
Publication  
First Author: Folorunso OO
Year: 2023
Journal: Neurosci Lett
Title: The D-serine biosynthetic enzyme serine racemase is expressed by reactive astrocytes in the amygdala of human and a mouse model of Alzheimer's disease.
Volume: 792
Pages: 136958
Publication
First Author: Zhong L
Year: 2023
Journal: Immunity
Title: TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration.
Volume: 56
Issue: 8
Pages: 1794-1808.e8
Publication
First Author: Li J
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: Synaptic P-Rex1 signaling regulates hippocampal long-term depression and autism-like social behavior.
Volume: 112
Issue: 50
Pages: E6964-72
Publication
First Author: Spielman L
Year: 2002
Journal: Acta Neuropathol
Title: Induction of the complement component C1qB in brain of transgenic mice with neuronal overexpression of human cyclooxygenase-2.
Volume: 103
Issue: 2
Pages: 157-62
Publication
First Author: Wang P
Year: 2023
Journal: Cell Biosci
Title: PI3K-AKT activation resculpts integrin signaling to drive filamentous tau-induced proinflammatory astrogliosis.
Volume: 13
Issue: 1
Pages: 179
Publication
First Author: Park JY
Year: 2015
Journal: Biochem Biophys Res Commun
Title: SIGN-R1 and complement factors are involved in the systemic clearance of radiation-induced apoptotic cells in whole-body irradiated mice.
Volume: 463
Issue: 4
Pages: 1064-70
Publication
First Author: Zhang Q
Year: 2017
Journal: Oncotarget
Title: MicroRNA-149* suppresses hepatic inflammatory response through antagonizing STAT3 signaling pathway.
Volume: 8
Issue: 39
Pages: 65397-65406
Publication
First Author: Tagliabracci VS
Year: 2011
Journal: Cell Metab
Title: Phosphate incorporation during glycogen synthesis and Lafora disease.
Volume: 13
Issue: 3
Pages: 274-82
Publication
First Author: Senaldi G
Year: 2002
Journal: J Immunol
Title: Regulatory effects of novel neurotrophin-1/b cell-stimulating factor-3 (cardiotrophin-like cytokine) on B cell function.
Volume: 168
Issue: 11
Pages: 5690-8
Publication
First Author: Dahl MR
Year: 2001
Journal: Immunity
Title: MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway.
Volume: 15
Issue: 1
Pages: 127-35
Publication
First Author: Verlaet M
Year: 2001
Journal: Biochem Biophys Res Commun
Title: Genetic imbalances in preleukemic thymuses.
Volume: 283
Issue: 1
Pages: 12-8
Publication
First Author: Schrijver G
Year: 1988
Journal: Lab Invest
Title: Antiglomerular basement membrane nephritis in the mouse. Study on the role of complement in the heterologous phase.
Volume: 59
Issue: 4
Pages: 484-91
Publication
First Author: Toda S
Year: 1989
Journal: Jikken Dobutsu
Title: Strain differences in histamine release from mouse peritoneal mast cells induced by compound 48/80 or A23187.
Volume: 38
Issue: 2
Pages: 135-7
Publication
First Author: In S
Year: 1990
Journal: J Clin Lab Immunol
Title: Treatment of end stage MRL-1pr/lpr mouse lupus disease by a cyclophosphazene derived drug and by cyclosporin A.
Volume: 32
Issue: 2
Pages: 85-90
Publication
First Author: Entani C
Year: 1993
Journal: Nephron
Title: Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice.
Volume: 64
Issue: 3
Pages: 471-5
Publication
First Author: Yoshida F
Year: 1994
Journal: Nephron
Title: Renal lesions of the FGS strain of mice: a spontaneous animal model of progressive glomerulosclerosis.
Volume: 66
Issue: 3
Pages: 317-25
Publication
First Author: Zenklusen JC
Year: 1996
Journal: Genome Res
Title: Novel susceptibility locus for mouse hepatomas: evidence for a conserved tumor suppressor gene.
Volume: 6
Issue: 11
Pages: 1070-6
Publication
First Author: Hirai A
Year: 1997
Journal: J Biol Chem
Title: Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells.
Volume: 272
Issue: 1
Pages: 13-6
Publication
First Author: Ji X
Year: 1997
Journal: Proc Natl Acad Sci U S A
Title: Ancient origin of the complement lectin pathway revealed by molecular cloning of mannan binding protein-associated serine protease from a urochordate, the Japanese ascidian, Halocynthia roretzi.
Volume: 94
Issue: 12
Pages: 6340-5
Publication
First Author: Noorchashm H
Year: 1999
Journal: Cell Immunol
Title: Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors.
Volume: 195
Issue: 1
Pages: 75-9
Publication
First Author: Matsumoto I
Year: 2002
Journal: Nat Immunol
Title: How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease.
Volume: 3
Issue: 4
Pages: 360-5